{
  "items": [
    {
      "title": "Are High-Yield Dividend Stocks Best for Income-Focused Investors?",
      "description": "Dividends come with many clear benefits, including a passive income stream and a shield against drawdowns in other positions.",
      "published_utc": "2025-03-11T07:04:00",
      "source": "Yahoo",
      "url": "https://finnhub.io/api/news?id=cdf431b26e840376c1ed4a347b7e1e05d545e53f81166debba7e988880a82b79",
      "category": "company",
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133184450,
      "datetime": 1741647840
    },
    {
      "title": "Johnson & Johnson - Icotrokinra results show potential to set a new standard of treatment in plaque psoriasis",
      "description": "SPRING HOUSE - Johnson & Johnson today announced new icotrokinra data from its comprehensive Phase 3 clinical program and the start of the first-ever head-to-head study in plaque psoriasis seeking...",
      "published_utc": "2025-03-10T20:39:20",
      "source": "Finnhub",
      "url": "https://finnhub.io/api/news?id=3263c10710231cbb6e510e225c0f7e187192b181425afcabeb46997b9c6a3312",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133122064,
      "datetime": 1741610360
    },
    {
      "title": "Genmab Shares Fall After J&J Drops Blood-Cancer Treatment Option",
      "description": "Genmab Shares Fall After J&J Drops Blood-Cancer Treatment Option",
      "published_utc": "2025-03-10T19:01:00",
      "source": "MarketWatch",
      "url": "https://finnhub.io/api/news?id=951910a318b37d2a9dc926640a43045d151550e30e14b359ca9b482011190688",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133123584,
      "datetime": 1741604460
    },
    {
      "title": "Genmab Stops Blood Cancer Treatment Development After J&J Won't License It",
      "description": "Genmab Stops Blood Cancer Treatment Development After J&J Won't License It",
      "published_utc": "2025-03-10T18:43:00",
      "source": "MarketWatch",
      "url": "https://finnhub.io/api/news?id=d6579e85e922701d5f72dc097b5e0086e106434b9f454af1bbdbc2d21020e599",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133118688,
      "datetime": 1741603380
    },
    {
      "title": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
      "description": "Protagonist Therapeutics Unveils 'Paradigm-Shifting' Drug And Breaks Out",
      "published_utc": "2025-03-10T18:19:46",
      "source": "DowJones",
      "url": "https://finnhub.io/api/news?id=a55d7493fb58c6cf6d7bc37bd29ce2e81811d28363bf7b4f62e782336c9cd1f8",
      "category": "company",
      "image": "",
      "related_symbols": [
        "JNJ"
      ],
      "api_source": "finnhub_company",
      "id": 133118668,
      "datetime": 1741601986
    }
  ],
  "metadata": {
    "cached_at": "2025-09-25T07:16:21.688254+00:00",
    "cache_key": "news_961df838fc84a2a7116d066ea0a0733d",
    "count": 5
  }
}